Related Experiment Video
Updated: Apr 19, 2026

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Single-cell transcriptomic analysis reveals novel lncRNA macromolecules associated with PARP11, LMF1, and RRM2
Ali Haider1, Rahman Ud Din1, Bushra Habib2
1Department of Biomedical Engineering, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.
Abstract:
Lung cancer remains a leading cause of cancer-related mortality, largely due to its complex immune microenvironment and molecular heterogeneity. To address gaps in understanding tumor heterogeneity and the role of long non-coding RNA (lncRNA) macromolecules, we conducted an integrative single-cell RNA sequencing (scRNA-seq) analysis of non-small cell lung cancer (NSCLC). Unsupervised clustering identified distinct immune and malignant cell populations. Differential expression analysis identified robust cell-type markers, including novel lncRNA macromolecules, AC005842.1, AC009041.2, and AC007240.1 enriched in specific tumor and immune subsets. Functional enrichment linked these lncRNAs to key cancer pathways, including epithelial-mesenchymal transition (EMT), hypoxia, and immune modulation. Targeted experimental validation using quantitative real-time PCR (qRT-PCR) in NSCLC cell lines confirmed significant upregulation of the identified lncRNAs and supported activation of EMT-associated molecular programs. Pseudotime trajectory modeling uncovered dynamic activation of hallmark programs, notably TNFA-NFκB and IL2-STAT5 signaling, suggesting progressive immune suppression and metabolic reprogramming during tumor evolution. We further identified novel transcription factor-pathway associations, including NR5A1-OXPHOS (oxidative phosphorylation) and FOXA2-mTORC1, pointing to uncharacterized axes of macromolecular regulation. To ensure reproducibility and accessibility, we developed lncScape, a modular, open-source Shiny application for integrative lncRNA analysis in single-cell datasets. lncScape implements a pipeline for clustering, lncRNA detection, pseudotime modeling, and GSVA-based pathway enrichment. It also introduces two novel scoring strategies the lncRNA Dynamics Score (LDS) and TF-lncRNA Dynamics (TLD) to prioritize dynamic regulatory lncRNAs based on expression patterns and transcription factor associations. Our findings expand understanding of lncRNA macromolecules in lung cancer and provide a practical platform for lncRNA-centric research.
Insights
This study reveals novel long non-coding RNAs (lncRNAs) in lung cancer, uncovering their role in tumor evolution and immune suppression. A new tool, lncScape, aids in analyzing these crucial lncRNA macromolecules.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Lung cancer is a leading cause of mortality, characterized by complex tumor heterogeneity and immune microenvironments.
- Understanding the role of long non-coding RNAs (lncRNAs) in non-small cell lung cancer (NSCLC) is crucial for developing new therapies.
- Existing research has gaps in characterizing lncRNA involvement in NSCLC's molecular landscape.
Purpose of the Study:
- To investigate the role of lncRNA macromolecules in NSCLC heterogeneity using single-cell RNA sequencing (scRNA-seq).
- To identify novel lncRNA markers and their associated molecular pathways in NSCLC.
- To develop a user-friendly platform for integrative lncRNA analysis in single-cell data.
Main Methods:
- Integrative single-cell RNA sequencing (scRNA-seq) analysis of NSCLC samples.
- Unsupervised clustering and differential expression analysis to identify cell populations and markers.
- Quantitative real-time PCR (qRT-PCR) for experimental validation of lncRNA expression.
- Pseudotime trajectory modeling and transcription factor-pathway association analysis.
- Development of the open-source Shiny application, lncScape, for lncRNA analysis.
Main Results:
- Identified distinct immune and malignant cell populations in NSCLC.
- Discovered novel lncRNAs (AC005842.1, AC009041.2, AC007240.1) enriched in specific tumor and immune subsets.
- Linked lncRNAs to key cancer pathways such as epithelial-mesenchymal transition (EMT), hypoxia, and immune modulation.
- Confirmed lncRNA upregulation and EMT activation via qRT-PCR.
- Uncovered dynamic activation of TNFA-NFκB and IL2-STAT5 signaling, indicating immune suppression and metabolic reprogramming.
- Identified novel transcription factor-pathway associations (NR5A1-OXPHOS, FOXA2-mTORC1).
Conclusions:
- This study enhances the understanding of lncRNA macromolecules in lung cancer pathogenesis and immune evasion.
- The identified lncRNAs and pathways offer potential therapeutic targets for NSCLC.
- The developed lncScape platform provides a valuable resource for future lncRNA-centric research in single-cell genomics.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons